Evaluation of a novel virtual care platform for remote monitoring of LVAD patients

Shreyans K. Patel; Anne Luke; Andrew Schutt; Thiru Chinnadurai; Aashna Pandya; Omar Saeed; Daniel Goldstein; Ulrich Jorde; Snehal R. Patel

doi:10.1016/j.healun.2022.02.005

Evaluation of a novel virtual care platform for remote monitoring of LVAD patients

Shreyans K. Patel, Anne Luke, Andrew Schutt, Thiru Chinnadurai, Aashna Pandya, Omar Saeed, Daniel Goldstein, Ulrich Jorde, Snehal R. Patel

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The aim of this study was to evaluate a novel virtual care platform created for use in Left Ventricular Assist Device (LVAD) patients. The platform included a daily log of LVAD parameters and medication adherence, two-way messaging with providers, and educational resources. To test the feasibility of this application, we recruited 25 patients between 2017 and 2019 and followed them for 6 months post discharge. Feedback concerning the platform was very positive with an average score of 4.5 ± 0.6 (out of 5) on usability and/or satisfaction and 8.1 ± 1.8 (out of 10) on likelihood to recommend the platform. In addition, our platform was well utilized with median (IQR) engagement rates of 87 (53,100)% at 30 days and 73 (49,95)% overall. We found that patients using the platform attended significantly less outpatient visits at the 6 month mark, however there was no difference in 30-day readmission rates compared to the overall LVAD cohort.

Original language	English (US)
Pages (from-to)	558-562
Number of pages	5
Journal	Journal of Heart and Lung Transplantation
Volume	41
Issue number	5
DOIs	https://doi.org/10.1016/j.healun.2022.02.005
State	Published - May 2022

Keywords

LVAD
patient satisfaction
readmissions
telehealth
virtual care

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine
Transplantation

Access to Document

10.1016/j.healun.2022.02.005

Cite this

@article{fbe815dbf8554b70b5809cac03d59e11,

title = "Evaluation of a novel virtual care platform for remote monitoring of LVAD patients",

abstract = "The aim of this study was to evaluate a novel virtual care platform created for use in Left Ventricular Assist Device (LVAD) patients. The platform included a daily log of LVAD parameters and medication adherence, two-way messaging with providers, and educational resources. To test the feasibility of this application, we recruited 25 patients between 2017 and 2019 and followed them for 6 months post discharge. Feedback concerning the platform was very positive with an average score of 4.5 ± 0.6 (out of 5) on usability and/or satisfaction and 8.1 ± 1.8 (out of 10) on likelihood to recommend the platform. In addition, our platform was well utilized with median (IQR) engagement rates of 87 (53,100)% at 30 days and 73 (49,95)% overall. We found that patients using the platform attended significantly less outpatient visits at the 6 month mark, however there was no difference in 30-day readmission rates compared to the overall LVAD cohort.",

keywords = "LVAD, patient satisfaction, readmissions, telehealth, virtual care",

author = "Patel, {Shreyans K.} and Anne Luke and Andrew Schutt and Thiru Chinnadurai and Aashna Pandya and Omar Saeed and Daniel Goldstein and Ulrich Jorde and Patel, {Snehal R.}",

note = "Publisher Copyright: {\textcopyright} 2022 International Society for Heart and Lung Transplantation",

year = "2022",

month = may,

doi = "10.1016/j.healun.2022.02.005",

language = "English (US)",

volume = "41",

pages = "558--562",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier USA",

number = "5",

}

TY - JOUR

T1 - Evaluation of a novel virtual care platform for remote monitoring of LVAD patients

AU - Patel, Shreyans K.

AU - Luke, Anne

AU - Schutt, Andrew

AU - Chinnadurai, Thiru

AU - Pandya, Aashna

AU - Saeed, Omar

AU - Goldstein, Daniel

AU - Jorde, Ulrich

AU - Patel, Snehal R.

PY - 2022/5

Y1 - 2022/5

N2 - The aim of this study was to evaluate a novel virtual care platform created for use in Left Ventricular Assist Device (LVAD) patients. The platform included a daily log of LVAD parameters and medication adherence, two-way messaging with providers, and educational resources. To test the feasibility of this application, we recruited 25 patients between 2017 and 2019 and followed them for 6 months post discharge. Feedback concerning the platform was very positive with an average score of 4.5 ± 0.6 (out of 5) on usability and/or satisfaction and 8.1 ± 1.8 (out of 10) on likelihood to recommend the platform. In addition, our platform was well utilized with median (IQR) engagement rates of 87 (53,100)% at 30 days and 73 (49,95)% overall. We found that patients using the platform attended significantly less outpatient visits at the 6 month mark, however there was no difference in 30-day readmission rates compared to the overall LVAD cohort.

AB - The aim of this study was to evaluate a novel virtual care platform created for use in Left Ventricular Assist Device (LVAD) patients. The platform included a daily log of LVAD parameters and medication adherence, two-way messaging with providers, and educational resources. To test the feasibility of this application, we recruited 25 patients between 2017 and 2019 and followed them for 6 months post discharge. Feedback concerning the platform was very positive with an average score of 4.5 ± 0.6 (out of 5) on usability and/or satisfaction and 8.1 ± 1.8 (out of 10) on likelihood to recommend the platform. In addition, our platform was well utilized with median (IQR) engagement rates of 87 (53,100)% at 30 days and 73 (49,95)% overall. We found that patients using the platform attended significantly less outpatient visits at the 6 month mark, however there was no difference in 30-day readmission rates compared to the overall LVAD cohort.

KW - LVAD

KW - patient satisfaction

KW - readmissions

KW - telehealth

KW - virtual care

UR - http://www.scopus.com/inward/record.url?scp=85126056553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126056553&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2022.02.005

DO - 10.1016/j.healun.2022.02.005

M3 - Article

C2 - 35279389

AN - SCOPUS:85126056553

SN - 1053-2498

VL - 41

SP - 558

EP - 562

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 5

ER -

Evaluation of a novel virtual care platform for remote monitoring of LVAD patients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this